Testosterone replacement therapy (TRT) · Health & Wellness
Sleep apnoea and TRT

TRT can worsen sleep apnoea and raise the red cell count, and both need watching. Why men on TRT should be screened for it, and what happens if it is found.
Sleep apnoea is a sleep disorder characterised by repeated episodes of stopping breathing and gasping or shallow breathing during sleep. It’s a common condition that affects millions of people worldwide and is associated with numerous health risks, including cardiovascular disease, diabetes and stroke. Many people use a machine to support their breathing during sleep, and this reduces their risk factors.
Testosterone replacement therapy (TRT) is a common treatment for men with low testosterone levels. Testosterone is a hormone that plays an important role in various bodily functions, including the development of male sexual characteristics, muscle growth and bone density. However, TRT has been associated with an increased risk of sleep apnoea.
The risk of sleep apnoea is concerning because one of the side effects of TRT is polycythaemia (also called erythrocytosis), and this is also made worse by sleep apnoea. As the number of red blood cells grows, the blood can become more viscous (thick). This increases the risk of stroke. Usually, men who develop polycythaemia can lower their testosterone dose or switch to a different formulation.
A systematic review and meta-analysis published in the Journal of Clinical Sleep Medicine investigated the association between TRT and sleep apnoea. The review included 24 studies with a total of 18,579 participants. The results showed that TRT was associated with an increased risk of sleep apnoea.
The exact mechanism by which TRT increases the risk of sleep apnoea is not fully understood. However, it is thought that testosterone may increase upper airway resistance and decrease muscle tone in the upper airway, leading to breathing difficulties during sleep.
While the association between TRT and sleep apnoea is well-established, the clinical implications of this association are still unclear. Some experts suggest that patients on TRT should be routinely screened for sleep apnoea and treated accordingly, while others argue that the evidence is not strong enough to support such recommendations.
One study published in the Journal of Clinical Endocrinology and Metabolism investigated the effects of TRT on sleep apnoea in men with low testosterone levels and obstructive sleep apnoea. The study included 49 men who were randomised to receive either TRT or a placebo for 12 weeks. The results showed that TRT did not worsen sleep apnoea, and may even have improved it in some cases.
Sleep apnoea affects millions of men, and it is worth thinking about before starting treatment. It is worth considering treatment for sleep apnoea before starting TRT. Regular blood tests would be needed. Further research is needed to determine the clinical implications of this association and to develop evidence-based recommendations for screening and treatment of sleep apnoea in patients on TRT.
References:
- Basaria S, Harman SM, Travison TG, et al. Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: A randomized clinical trial. JAMA. 2015;314(6):570 to 581. doi:10.1001/jama.2015.8881
Reading is a good start; a blood test and a conversation with a clinician are where it becomes useful. Ring 0333 335 6414, or start with the tools on the resources page.
Ask us
If you have any questions, just ask us.
You do not have to work out which appointment you need, and you do not have to write anything down. Leave your name, number and email, pick roughly what it is about, and a person rings you back within one working day.